Matches in Nanopublications for { ?s ?p "[Moreover, HCC patients with unmethylated CD147 promoter had a significantly higher recurrence rate (88.1%versus 58.3%; P < 0.05) and death rate (83.3%versus 50.0%; P < 0.05) than patients with methylated CD147 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP274262.RAnV9h3o0MyijZboAuGjsObuvYkGGcjxxT-UTv-SyGiAM130_assertion description "[Moreover, HCC patients with unmethylated CD147 promoter had a significantly higher recurrence rate (88.1%versus 58.3%; P < 0.05) and death rate (83.3%versus 50.0%; P < 0.05) than patients with methylated CD147 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274262.RAnV9h3o0MyijZboAuGjsObuvYkGGcjxxT-UTv-SyGiAM130_provenance.